Intramuscular Route Articles & Analysis
2 articles found
All biologics are injected using either subcutaneous, intramuscular or intravenous routes. The global biologics market reached sales of $250-billion in 2020, of which the total addressable market for Rani’s pipeline is $56-billion plus initial market opportunities targeting multiple markets across multiple diseases. ...
In recent years, in addition to the classical subcutaneous, intramuscular and intravenous administration, other routes of administration have been progressively developed, including mucosal administration (nasal, pulmonary or sublingual), oral administration (gastrointestinal permeation promoters, protease inhibitors or carriers) and transdermal ...